For the 16th year running, the Congress of the European Retina, Macula and Vitreous Society (EURETINA) brings together specialists and experts of the ophthalmology community.
With several ongoing research programs focusing on a range of eye diseases that cause significant visual impairment and blindness, Roche is committed to improving eye health. We focus on addressing the leading causes of blindness, including geographic atrophy (GA) secondary to age-related macular degeneration (AMD), neovascular AMD, diabetic macular edema and other retinal diseases.
GA is an advanced form of AMD characterised by a progressive, irreversible loss of retina. The resulting loss of visual function means people suffering from GA often have difficulties performing daily tasks, such as reading, recognising faces or driving. At EURETINA Roche will be providing insights into the natural history of GA, as well as new real-world data on the impact of GA on everyday life.